SARS-CoV-2 NSP12 (YP_009725307.1) VersaClone cDNA Summary
Specifications
Product Datasheets
Background: NSP12
Citation for SARS-CoV-2 NSP12 (YP_009725307.1) VersaClone cDNA
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
Enhanced In Vitro Antiviral Activity of Hydroxychloroquine Ionic Liquids against SARS-CoV-2
Authors: F Faísca, V Correia, Ž Petrovski, LC Branco, H Rebelo-de-, MM Santos
Pharmaceutics, 2022-04-17;14(4):. 2022-04-17
FAQs
No product specific FAQs exist for this product, however you may
View all cDNA Clone FAQsReviews for SARS-CoV-2 NSP12 (YP_009725307.1) VersaClone cDNA
There are currently no reviews for this product. Be the first to review SARS-CoV-2 NSP12 (YP_009725307.1) VersaClone cDNA and earn rewards!
Have you used SARS-CoV-2 NSP12 (YP_009725307.1) VersaClone cDNA?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image